Plant-based meals improve insulin and incretin secretion in those with type 2 diabetes

February 27, 2019

WASHINGTON - A plant-based diet improves the secretion of insulin and incretin hormones in those with type 2 diabetes, according to new research published in Nutrients.

Researchers compared the effects of a plant-based meal to a meal containing meat on the hormone levels of a group of 20 men who have type 2 diabetes in a randomized crossover trial. The meals consisted of either a tofu-based veggie burger or a meat-based burger and contained the same amount of calories and ratio of macronutrients.

The results show that participants' postprandial secretion of insulin increased more after the plant-based meal than the meat-based meal. Secretion of incretin hormones, particularly glucagon-like-peptide 1 (GLP-1), also increased more after the vegan meal. Incretin hormones amplify the release of insulin after a meal and also help decrease blood glucose levels.

Beta-cell function parameters also improved after the vegan meal. Beta cells synthesize, store, and release insulin. Beta-cell function is typically diminished in those who have diabetes, and preserving beta cells' capacity to produce insulin is a cornerstone in the treatment of diabetes.

"With diabetes rates rising and insulin costs soaring, this study offers hope that a solution could be close at hand: the food on our plates," says study author Hana Kahleova, M.D., Ph.D., director of clinical research at the Physicians Committee for Responsible Medicine. "The results add to the evidence that a plant-based diet should be considered a frontline treatment for type 2 diabetes."

A previous study found that a 16-week plant-based dietary intervention improves insulin resistance and beta-cell function in overweight adults. Other studies have shown that plant-based diets are effective in managing and even reversing type 2 diabetes and that those following a plant-based diet have approximately half the risk of developing diabetes, compared with non-vegetarians.

In the United States today, more than 114 million adults have either diabetes or prediabetes.
-end-
For a copy of the study or an interview with Dr. Kahleova, please contact Laura Anderson at 202-527-7396 or landerson@PCRM.org.

Physicians Committee for Responsible Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.